The Study:
Enzyme therapy -a method of immune therapy for women with a history of immunologically-induced habitual abortion
Dittmar, F.-W. Offprint from Forum Immunologie 3/2000
Abstract
Background:
For women with a history of immunologically-induced habitual abortion, only a few therapies are currently available which are also known to be associated with a limited rate of success and substantial side effects.
Objective:
The goal of this investigation was to evaluate the benefits of a systemic enzyme therapy in pregnant women with a history of habitual abortion based upon the course of pregnancy and delivery, and also including the “fetal outcome’.
Materials and methods:
144 pregnant women with immunologically-induced abortion received a gestagen preparation and an enzyme combination preparation, and were observed until the time of delivery. The standard data concerning pregnancy, birth and the child were collected and evaluated.
Results:
114 of the 144 erizyme-treated women demonstrated an inconspicuous course of pregnancy up to the birth of their 114 healthy children (79% success rate). The enzyme therapy was seen to cause no unpleasant side effects.
Conclusions:
For immunologically-induced habitual abortion, enzyme therapy is seen to be an effective form of immune therapy. The maternal immune system is stabilized by the enzymes administered, thereby affording relief during the full-term development of a pregnancy. The further clarification of the molecular mechanisms of action of these agents is the subject of current research projects. Enzyme therapy can primarily be recommended for women who have suffered several abortions, in spite of the fact that they had received the common forms of immune therapy, and who are consequently looking for a therapeutic alternative. According to experiences made to date, enzyme therapy is considered to be very successtul for women with a history of habitual abortion and can be reflected in their completed pregnancies. Furthermore, it is tolerated well and also seen to be quite economical.
Comments:
This study is an amazing discovery for women who have experienced immunologically-induced recurrent miscarriages. The results of the study, simplified, are as follows:
There were 144 women treated using the systemic enzyme blend Wobenzym N. Of these 144, 114 were able to carry out their prgnancies and gave birth to healthy babies. This is a 79% success rate with no unpleasent side-effects.
Given the alternative options and costs to medically treat immunolically-induced miscarriages (around $12,000 +), enzyme therapy is very promissing and affordable option.
I have included a link above to the study in its entirety so you can show it to your doctor/health care provider.
Click here to learn more about natural therapies and recurrent miscarriages.
Hello
Thanks for the article! There seems to be no mention of dosage used for Wobenzym N or Phlogenzyme in your article here or through the body of the published study. Do you know where this can be found? Or have any idea of the dose used to treat these subjects? Thank you.
Dear Kali,
Learn more about Systemic Enzyme Therapy using Wobenzym N here… including how it is known to benefit fertility health and general dosage guidelines.
Take care!
I have a possible autoimmune implantation issue. Can I combine systemic enzymes with intralipid therapy? Would this be safe?
Dear Karina,
It will be best to consult the healthcare provider from whom you are receiving the Intralipid Therapy. However, to my knowledge Intralipid Therapy provides essential fatty acids in order to help lower the activity of natural killer (NK) cells and Systemic Enzyme Therapy can be combined with essential fatty acids in capsule form as well as eaten in your diet. Take time to learn How to Use Systemic Enzyme Therapy to Increase Your Fertility here…
Update 2014 – We are back! We have been away for a while and we sure have missed all of your wonderful questions and thoughts on our articles. Moving forward, one of our staff herbalists will be here to respond to comments! We look forward to connecting with our readers once again!
I was wondering how this connection is made to a woman who has suffered recurrent miscarriages? Does one have to under go a test? In January, 2008 I had a partial molar pregnancy. In January of 2009 I suffered another miscarriage of two blighted ovum’s. In February of 2010 I suffered a miscarriage of one viable baby at 10 weeks gestation at which time they also discovered an additional empty sac and called this a blighted ovum. These losses have followed four seperate healthy pregnancies with four healthy children which I carried to term. Since the last miscarriage I have been unable to achieve pregnancy. After each miscarriage my body stalled and at my request my doctor waited to perform a D&C in all cases a couple of months. I am wondering just how much scar tissue is now present and was interested in the enzyme therapy. My doctor sent me to a specialist and they could find no genetic problem. For about a year now I have been eating all soaked or sprouted grains along with all organic food including grass fed organic beef. I practice food combining and do not consume junk food. I have just turned 38 and know that my chances for conception are getting lower the older I get. However I wonder if you might have some insight as I feel like I may be missing something. Thank you, Kori
Hi Kori,
These women did have testing done to determine there may be an immune response in their bodies that went awry. You can learn causes of blighted ovum and what may be able to be done about it here: http://natural-fertility-info.com/what-is-blighted-ovum-pregnancy-loss.html
Another consideration: Asherman’s syndrome is caused by damage to the uterus that causes the formation of adhesions (scar tissue). This may cause miscarriage or make it impossible/difficult for the embryo to attach to the uterine wall and develop.
The number one cause of Asherman’s syndrome is D&C (diallation and cutterage) procedure. 90% of Asherman’s cases are due to pregnancy related D&C. Women who have had a D&C have a 25% risk of developing Asherman’s 2-4 weeks post-procedure. D&C performed for missed miscarriage have a 30.9% chance of developing Asherman’s, where as women who have had a D&C due to an incomplete miscarriage only have a 6.4% chance of developing Asherman’s. Women who have had more than 2 D&C’s have an increased chance of developing Asherman’s by 32%.
Best Wishes,
Dalene